Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer

Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer

To treat superficial bladder cancer or invasive bladder cancer presenting as a solitary tumor, conservative therapy such as transurethral resection of bladder tumor or partial cystectomy has long been carried out. We studied the effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU), and the effects of th...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 38(1992), 1 vom: 31. Jan., Seite 19-24
1. Verfasser: Wada, S (VerfasserIn)
Weitere Verfasser: Yasumoto, R, Kashihara, N, Kishimoto, T, Maekawa, M, Hayahara, N, Kawakita, J, Nishijima, T, Morikawa, Y, Horii, A
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1992
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article aceglatone 347Q3OOJ13 carmofur HA82M3RAB2 Glucaric Acid QLZ991V4A2 Fluorouracil U3P01618RT